-
1
-
-
25444440875
-
The role of autophagy in cancer development and response to therapy
-
Kondo Y, Kanzawa T, Sawaya R, Kondo S. The role of autophagy in cancer development and response to therapy. Nat Rev Cancer 2005; 5:726-34.
-
(2005)
Nat Rev Cancer
, vol.5
, pp. 726-734
-
-
Kondo, Y.1
Kanzawa, T.2
Sawaya, R.3
Kondo, S.4
-
2
-
-
33645944960
-
Autophagy and cancer therapy
-
Kondo Y, Kondo S. Autophagy and cancer therapy. Autophagy 2006; 2:85-90.
-
(2006)
Autophagy
, vol.2
, pp. 85-90
-
-
Kondo, Y.1
Kondo, S.2
-
3
-
-
12944303650
-
Growth factor regulation of autophagy and cell survival in the absence of apoptosis
-
Lum JJ, Bauer DE, Kong M, Harris MH, Li C, Lindsten T, Thompson CB. Growth factor regulation of autophagy and cell survival in the absence of apoptosis. Cell 2005; 120:237-48.
-
(2005)
Cell
, vol.120
, pp. 237-248
-
-
Lum, J.J.1
Bauer, D.E.2
Kong, M.3
Harris, M.H.4
Li, C.5
Lindsten, T.6
Thompson, C.B.7
-
4
-
-
25144506835
-
Autophagy in cell death: An innocent convict?
-
Levine B, Yuan J. Autophagy in cell death: an innocent convict? J Clin Invest 2005; 115:2679-88.
-
(2005)
J Clin Invest
, vol.115
, pp. 2679-2688
-
-
Levine, B.1
Yuan, J.2
-
5
-
-
2642553881
-
Regulation of an ATG7-beclin 1 program of autophagic cell death by caspase-8
-
Yu L, Alva A, Su H, Dutt P, Freundt E, Welsh S, Baehrecke EH, Lenardo MJ. Regulation of an ATG7-beclin 1 program of autophagic cell death by caspase-8. Science 2004; 304:1500-2.
-
(2004)
Science
, vol.304
, pp. 1500-1502
-
-
Yu, L.1
Alva, A.2
Su, H.3
Dutt, P.4
Freundt, E.5
Welsh, S.6
Baehrecke, E.H.7
Lenardo, M.J.8
-
6
-
-
10344262564
-
Role of Bcl-2 family proteins in a non-apoptotic programmed cell death dependent on autophagy genes
-
Shimizu S, Kanaseki T, Mizushima N, Mizuta T, Arakawa-Kobayashi S, Thompson CB, Tsujimoto Y. Role of Bcl-2 family proteins in a non-apoptotic programmed cell death dependent on autophagy genes. Nat Cell Biol 2004; 6:1221-8.
-
(2004)
Nat Cell Biol
, vol.6
, pp. 1221-1228
-
-
Shimizu, S.1
Kanaseki, T.2
Mizushima, N.3
Mizuta, T.4
Arakawa-Kobayashi, S.5
Thompson, C.B.6
Tsujimoto, Y.7
-
7
-
-
33745713171
-
Autophagy promotes tumor cell survival and restricts necrosis, inflammation, and tumorigenesis
-
Degenhardt K, Mathew R, Beaudoin B, Bray K, Anderson D, Chen G, Mukherjee C, Shi Y, Gelinas C, Fan Y, Nelson DA, Jin S, White E. Autophagy promotes tumor cell survival and restricts necrosis, inflammation, and tumorigenesis. Cancer Cell 2006; 10:51-64.
-
(2006)
Cancer Cell
, vol.10
, pp. 51-64
-
-
Degenhardt, K.1
Mathew, R.2
Beaudoin, B.3
Bray, K.4
Anderson, D.5
Chen, G.6
Mukherjee, C.7
Shi, Y.8
Gelinas, C.9
Fan, Y.10
Nelson, D.A.11
Jin, S.12
White, E.13
-
8
-
-
33846794896
-
Autophagy inhibition enhances therapy-induced apoptosis in a Myc-induced model of lymphoma
-
Amaravadi RK, Yu D, Lum JJ, Bui T, Christophorou MA, Evan GI, Thomas-Tikhonenko A, Thompson CB. Autophagy inhibition enhances therapy-induced apoptosis in a Myc-induced model of lymphoma. J Clin Invest 2007; 117:326-36.
-
(2007)
J Clin Invest
, vol.117
, pp. 326-336
-
-
Amaravadi, R.K.1
Yu, D.2
Lum, J.J.3
Bui, T.4
Christophorou, M.A.5
Evan, G.I.6
Thomas-Tikhonenko, A.7
Thompson, C.B.8
-
9
-
-
34347394714
-
Targeting autophagy augments the anticancer activity of the histone deacerylase inhibitor SAHA to overcome Bcr-Abl-mediated drug resistance
-
Carew JS, Nawrocki ST, Kahue CN, Zhang H, Yang C, Chung L, Houghton JA, Huang P, Giles FJ, Cleveland JL. Targeting autophagy augments the anticancer activity of the histone deacerylase inhibitor SAHA to overcome Bcr-Abl-mediated drug resistance. Blood 2007; 110:313-22.
-
(2007)
Blood
, vol.110
, pp. 313-322
-
-
Carew, J.S.1
Nawrocki, S.T.2
Kahue, C.N.3
Zhang, H.4
Yang, C.5
Chung, L.6
Houghton, J.A.7
Huang, P.8
Giles, F.J.9
Cleveland, J.L.10
-
10
-
-
40449086885
-
Blocked autophagy sensitizes resistant carcinoma cells to radiation therapy
-
Apel A, Herr I, Schwarz H, Rodemann HP, Mayer A. Blocked autophagy sensitizes resistant carcinoma cells to radiation therapy. Cancer Res 2008; 68:1485-94.
-
(2008)
Cancer Res
, vol.68
, pp. 1485-1494
-
-
Apel, A.1
Herr, I.2
Schwarz, H.3
Rodemann, H.P.4
Mayer, A.5
-
11
-
-
0038320035
-
Apo2L/TRAIL: Apoptosis signaling, biology, and potential for cancer therapy
-
Almasan A, Ashkenazi A. Apo2L/TRAIL: apoptosis signaling, biology, and potential for cancer therapy. Cytokine Growth Factor Rev 2003; 14:337-48.
-
(2003)
Cytokine Growth Factor Rev
, vol.14
, pp. 337-348
-
-
Almasan, A.1
Ashkenazi, A.2
-
12
-
-
35348881412
-
TRAIL death receptors and cancer therapeutics
-
Huang Y. TRAIL death receptors and cancer therapeutics. Toxicol Appl Pharmacol 2007; 224:284-9.
-
(2007)
Toxicol Appl Pharmacol
, vol.224
, pp. 284-289
-
-
Huang, Y.1
-
13
-
-
0033662433
-
Apo2L/TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5
-
Kischkel FC, Lawrence DA, Chuntharapai A, Schow P, Kim KJ, Ashkenazi A. Apo2L/TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5. Immunity 2000; 12:611-20.
-
(2000)
Immunity
, vol.12
, pp. 611-620
-
-
Kischkel, F.C.1
Lawrence, D.A.2
Chuntharapai, A.3
Schow, P.4
Kim, K.J.5
Ashkenazi, A.6
-
14
-
-
0033667778
-
FADD/MORT1 and caspase-8 are recruited to TRAIL receptors 1 and 2 and are essential for apoptosis mediated by TRAIL receptor 2
-
Sprick MR, Weigand MA, Rieser E, Rauch CT, Juo P, Blenis J, Krammer PH, Walczak H. FADD/MORT1 and caspase-8 are recruited to TRAIL receptors 1 and 2 and are essential for apoptosis mediated by TRAIL receptor 2. Immunity 2000; 12:599-609.
-
(2000)
Immunity
, vol.12
, pp. 599-609
-
-
Sprick, M.R.1
Weigand, M.A.2
Rieser, E.3
Rauch, C.T.4
Juo, P.5
Blenis, J.6
Krammer, P.H.7
Walczak, H.8
-
15
-
-
0036141029
-
TRAIL-induced apoptosis requires Bax-dependent mitochondrial release of Smac/DIABLO
-
Deng Y, Lin Y, Wu X. TRAIL-induced apoptosis requires Bax-dependent mitochondrial release of Smac/DIABLO. Genes Dev 2002; 16:33-45.
-
(2002)
Genes Dev
, vol.16
, pp. 33-45
-
-
Deng, Y.1
Lin, Y.2
Wu, X.3
-
16
-
-
0036131142
-
Tumor-cell resistance to death receptor-induced apoptosis through mutational inactivation of the proapoptotic Bcl-2 homolog Bax
-
LeBlanc H, Lawrence D, Varfolomeev E, Torpal K, Morlan J, Schow P, Fong S, Schwall R, Sinicropi D, Ashkenazi A. Tumor-cell resistance to death receptor-induced apoptosis through mutational inactivation of the proapoptotic Bcl-2 homolog Bax. Nat Med 2002; 8:274-81.
-
(2002)
Nat Med
, vol.8
, pp. 274-281
-
-
LeBlanc, H.1
Lawrence, D.2
Varfolomeev, E.3
Torpal, K.4
Morlan, J.5
Schow, P.6
Fong, S.7
Schwall, R.8
Sinicropi, D.9
Ashkenazi, A.10
-
18
-
-
0034037333
-
Apoptosis induced by death receptors
-
Schneider P, Tschopp J. Apoptosis induced by death receptors. Pharm Acta Helv 2000; 74:281-6.
-
(2000)
Pharm Acta Helv
, vol.74
, pp. 281-286
-
-
Schneider, P.1
Tschopp, J.2
-
19
-
-
33747623259
-
Multiple mechanisms underlie resistance of leukemia cells to Apo2 Ligand/TRAIL
-
Cheng J, Hylander BL, Baer MR, Chen X, Repasky EA. Multiple mechanisms underlie resistance of leukemia cells to Apo2 Ligand/TRAIL. Mol Cancer Ther 2006; 5:1844-53.
-
(2006)
Mol Cancer Ther
, vol.5
, pp. 1844-1853
-
-
Cheng, J.1
Hylander, B.L.2
Baer, M.R.3
Chen, X.4
Repasky, E.A.5
-
20
-
-
14644437742
-
Mechanisms of resistance to TRAIL-induced apoptosis in cancer
-
Zhang L, Fang B. Mechanisms of resistance to TRAIL-induced apoptosis in cancer. Cancer Gene Ther 2005; 12:228-37.
-
(2005)
Cancer Gene Ther
, vol.12
, pp. 228-237
-
-
Zhang, L.1
Fang, B.2
-
21
-
-
1542513774
-
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is required for induction of autophagy during lumen formation in vitro
-
Mills KR, Reginato M, Debnath J, Queenan B, Brugge JS. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is required for induction of autophagy during lumen formation in vitro. Proc Natl Acad Sci U S A 2004; 101:3438-43.
-
(2004)
Proc Natl Acad Sci U S A
, vol.101
, pp. 3438-3443
-
-
Mills, K.R.1
Reginato, M.2
Debnath, J.3
Queenan, B.4
Brugge, J.S.5
-
22
-
-
34547624687
-
Kim sYS. A human scFv antibody against TRAIL receptor 2 induces autophagic cell death in both TRAIL-sensitive and TRAIL-resistant cancer cells
-
Park KJ, Lee SH, Kim TI, Lee HW, Lee CH, Kim EH, Jang JY, Choi KS, Kwon MH, Kim sYS. A human scFv antibody against TRAIL receptor 2 induces autophagic cell death in both TRAIL-sensitive and TRAIL-resistant cancer cells. Cancer Res 2007; 67:7327-34.
-
(2007)
Cancer Res
, vol.67
, pp. 7327-7334
-
-
Park, K.J.1
Lee, S.H.2
Kim, T.I.3
Lee, H.W.4
Lee, C.H.5
Kim, E.H.6
Jang, J.Y.7
Choi, K.S.8
Kwon, M.H.9
-
23
-
-
33744507693
-
Interrelated roles for Mcl-1 and BIM in regulation of TRAIL-mediated mitochondrial apoptosis
-
Han J, Goldstein LA, Gastman BR, Rabinowich H. Interrelated roles for Mcl-1 and BIM in regulation of TRAIL-mediated mitochondrial apoptosis. J Biol Chem 2006; 281:10153-63.
-
(2006)
J Biol Chem
, vol.281
, pp. 10153-10163
-
-
Han, J.1
Goldstein, L.A.2
Gastman, B.R.3
Rabinowich, H.4
-
24
-
-
50349098812
-
Involvement of protective autophagy in TRAIL resistance of apoptosis-defective tumor cells
-
Han J, Hou W, Goldstein LA, Lu C, Stolz DB, Yin XM, Rabinowich H. Involvement of protective autophagy in TRAIL resistance of apoptosis-defective tumor cells. J Biol Chem 2008; 283:19665-77.
-
(2008)
J Biol Chem
, vol.283
, pp. 19665-19677
-
-
Han, J.1
Hou, W.2
Goldstein, L.A.3
Lu, C.4
Stolz, D.B.5
Yin, X.M.6
Rabinowich, H.7
-
25
-
-
33749162486
-
Calpain-mediated cleavage of Atg5 switches autophagy to apoptosis
-
Yousefi S, Perozzo R, Schmid I, Ziemiecki A, Schaffner T, Scapozza L, Brunner T, Simon HU. Calpain-mediated cleavage of Atg5 switches autophagy to apoptosis. Nat Cell Biol 2006; 8:1124-32.
-
(2006)
Nat Cell Biol
, vol.8
, pp. 1124-1132
-
-
Yousefi, S.1
Perozzo, R.2
Schmid, I.3
Ziemiecki, A.4
Schaffner, T.5
Scapozza, L.6
Brunner, T.7
Simon, H.U.8
-
26
-
-
34248998801
-
L and a BH3-like domain in Beclin-1
-
L and a BH3-like domain in Beclin-1. EMBO J 2007; 26:2527-39.
-
(2007)
EMBO J
, vol.26
, pp. 2527-2539
-
-
Maiuri, M.C.1
Le Toumelin, G.2
Criollo, A.3
Rain, J.C.4
Gautier, F.5
Juin, P.6
Tasdemir, E.7
Pierron, G.8
Troulinaki, K.9
Tavernarakis, N.10
Hickman, J.A.11
Geneste, O.12
Kroemer, G.13
-
27
-
-
34249037565
-
L-Beclin 1 peptide complex: Beclin 1 is a novel BH3-only protein
-
L-Beclin 1 peptide complex: Beclin 1 is a novel BH3-only protein. J Biol Chem 2007; 282:13123-32.
-
(2007)
J Biol Chem
, vol.282
, pp. 13123-13132
-
-
Oberstein, A.1
Jeffrey, P.D.2
Shi, Y.3
-
28
-
-
34249819032
-
BH3-only proteins trigger cytochrome c release, but how?
-
Hacker G, Weber A. BH3-only proteins trigger cytochrome c release, but how? Arch Biochem Biophys 2007; 462:150-5.
-
(2007)
Arch Biochem Biophys
, vol.462
, pp. 150-155
-
-
Hacker, G.1
Weber, A.2
-
29
-
-
0033635733
-
BH3-Only proteins-essential initiators of apoptotic cell death
-
Huang DC, Strasser A. BH3-Only proteins-essential initiators of apoptotic cell death. Cell 2000; 103:839-42.
-
(2000)
Cell
, vol.103
, pp. 839-842
-
-
Huang, D.C.1
Strasser, A.2
-
30
-
-
25144457455
-
Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy
-
Pattingre S, Tassa A, Qu X, Garuti R, Liang XH, Mizushima N, Packer M, Schneider MD, Levine B. Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy. Cell 2005; 122:927-39.
-
(2005)
Cell
, vol.122
, pp. 927-939
-
-
Pattingre, S.1
Tassa, A.2
Qu, X.3
Garuti, R.4
Liang, X.H.5
Mizushima, N.6
Packer, M.7
Schneider, M.D.8
Levine, B.9
|